Question Folks,
is the proposed sale for the SPMS treatment or MIS416 or both?
My view is that potentially MIS416, is the gift that could keep giving. If MIS 416 is the modulator to which treatments are attached, retaining MIS416 is crucial for IIL.
There are many more "treatments" that could potentially be used, similar to the SPMS treatment?
Ann: Phase 2B Update - Patients Wanting Access to Drug Post Trial, page-10
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.011(10.0%) |
Mkt cap ! $27.20M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.9¢ | $12.21K | 121.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 97518 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 50700 | 2 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |